Severe Neurologic Disorders in 2 Fetuses with Zika Virus Infection, Colombia
Jorge Acosta-Reyes
, Edgar Navarro, Maria José Herrera, Eloina Goenaga, Martha L. Ospina, Edgar Parra, Marcela Mercado, Pablo Chaparro, Mauricio Beltran, Maria Luz Gunturiz, Lissethe Pardo, Catalina Valencia, Sandra Huertas, Jorge Rodríguez, Germán Ruiz, Diana Valencia, Lisa B. Haddad, Sarah C. Tinker, Cynthia A. Moore, and Hernando Baquero
Author affiliations: Universidad del Norte, Barranquilla, Colombia (J. Acosta-Reyes, E. Navarro, M.J. Herrera, H. Baquero); Secretaría de Salud de Barranquilla, Barranquilla (E. Goenaga); Instituto Nacional de Salud, Bogotá, Colombia (M.L. Ospina, E. Parra, M. Mercado, P. Chaparro, M. Beltrán, M.L. Gunturiz, L. Pardo); Clínica Colsanitas, Clínica Reina Sofía, Bogotá (C. Valencia, S. Huertas, J. Rodríguez, G. Ruiz); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D. Valencia, S.C. Tinker, C.A. Moore); Emory University School of Medicine, Atlanta (L.B. Haddad).
Main Article
Figure 1
Figure 1. Pathology findings for case 1, involving a fetus examined after pregnancy termination who had severe neurologic defects attributed to maternal Zika virus infection, Colombia. A) Remnant tissue of cerebral cortex showing a reduced neuroblast layer (dotted lines) and hemorrhagic foci (arrow). Hematoxylin and eosin (H&E) staining; original magnification ×40. B) Glial leptomeningeal heterotopy showing congestive blood vessels (arrowhead) and foci of glial heterotopia (arrows). H&E staining; original magnification ×10. C) Glial leptomeningeal heterotopy showing congestive blood vessels (arrowhead) and foci of glial heterotopia (arrows). H&E staining; original magnification ×40.
Main Article
Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.